Signet Healthcare Partners — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
BiotechDublin 2
Jason Spees(Executive Officer, Director)Shlomi Nachman(Director)Paul Bae(Executive Officer)Konstantin Poukalov(Director)Robert Faulkner(Director)Shlomo Ben-Haim(Director)
Board seatJoyce Erony· per SEC Form D · $60M raise · filed Jan 2021
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device for managing chronic phantom limb pain and residual limb pain in adults with lower limb loss.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President, Chief Executive Officer, and Secretary)Zach Stassen(Chief Financial Officer)Claiborne R. Rankin(Director)Robert J. Centa(Chief Financial Officer)Joseph J. Jankowski(Director)Scott F. Drees(Director)
Board seatJoyce Erony· per SEC Form D · $42.8M raise · filed Nov 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.